XML 99 R87.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights (Details)
6 Months Ended
Jul. 31, 2023
$ / shares
Apr. 28, 2023
$ / shares
Jul. 29, 2022
$ / shares
Apr. 29, 2022
$ / shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Nov. 19, 2018
$ / shares
Per share data:                
Net asset value at beginning of period         $ 17.29 $ 17.04    
Net investment income         1.1 0.75    
Net realized gain (loss)         (0.27) 0.08    
Net change in unrealized appreciation         0.08 (0.04)    
Net increase in net assets resulting from operations         0.91 0.79    
Stockholder distributions from income $ (0.38) $ (0.38) $ (0.34) $ (0.34) (0.76) (0.68)    
Net asset value at end of period         $ 17.44 $ 17.15    
Net assets at end of period | $         $ 1,125,779 $ 1,107,014 $ 1,116,391,000  
Shares outstanding at end of period | shares         64,562,265.27 64,562,265.27    
Per share market value at end of period         $ 13.51 $ 13.61    
Total return based on market value         20.44 (6.28)    
Total return based on net asset value         5.29% 4.65%    
Ratios:                
Ratio of net investment income to average net assets         14.34 9.51    
Ratio of total net expenses to average net assets         12.78 8.43    
Supplemental data:                
Ratio of interest and debt financing expenses to average net assets         7.21 3.95    
Ratio of expenses (without incentive fees) to average net assets         11.43% 7.76%    
Ratio of incentive fees and management fees, net of contractual and voluntary waivers, to average net assets         4.60% 3.73%    
Average principal debt outstanding | $         $ 1,476,709 $ 1,267,665    
Portfolio turnover         21.1 18.66    
Ratio of Voluntary incentive fee waiver to average net assets         0.00% 0.00%    
Ratio of voluntary management fee waiver to average net assets         0 0    
Ratio of Income without voluntary fee waiver and voluntary and management fee         14.34 9.51    
Ratio of total expenses without voluntary incentive fee waiver to average net assets         12.78 8.43    
IPO                
Supplemental data:                
Public offering price               $ 20.25